- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-7347
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Radiotherapy plus EGFR inhibitors: synergistic modalities ; volume:2 ; number:1 ; day:18 ; month:1 ; year:2017 ; pages:1-9 ; date:12.2017
Cancers of the head & neck ; 2, Heft 1 (18.1.2017), 1-9, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Bossi, Paolo
- Beteiligte Personen und Organisationen
-
Platini, Francesca
SpringerLink (Online service)
- DOI
-
10.1186/s41199-016-0020-y
- URN
-
urn:nbn:de:1111-201702154993
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bossi, Paolo
- Platini, Francesca
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery
Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer
Alethic Modalities, Temporal Modalities, and Representation
Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment
Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren
Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors
EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer
Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery
Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer
Alethic Modalities, Temporal Modalities, and Representation
Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment
Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren
Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors
EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer
Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery
Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer
Alethic Modalities, Temporal Modalities, and Representation
Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment
Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren
Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors
EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer